BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33680863)

  • 1. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy.
    Subramaniyan V; Chakravarthi S; Jegasothy R; Seng WY; Fuloria NK; Fuloria S; Hazarika I; Das A
    Toxicol Rep; 2021; 8():376-385. PubMed ID: 33680863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Medical Treatment for Alcohol-Associated Liver Disease.
    Ayares G; Idalsoaga F; Díaz LA; Arnold J; Arab JP
    J Clin Exp Hepatol; 2022; 12(5):1333-1348. PubMed ID: 36157148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Alcohol-Associated Liver Disease.
    Osna NA; Rasineni K; Ganesan M; Donohue TM; Kharbanda KK
    J Clin Exp Hepatol; 2022; 12(6):1492-1513. PubMed ID: 36340300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut barrier for the treatment of alcoholic liver disease.
    Zhou Z; Zhong W
    Liver Res; 2017 Dec; 1(4):197-207. PubMed ID: 30034913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury
    Pi A; Jiang K; Ding Q; Lai S; Yang W; Zhu J; Guo R; Fan Y; Chi L; Li S
    Front Pharmacol; 2021; 12():752148. PubMed ID: 34603062
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis.
    Wakil A; Niazi M; Meybodi MA; Pyrsopoulos NT
    J Clin Exp Hepatol; 2023; 13(1):116-126. PubMed ID: 36647403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and therapy of alcoholic liver disease.
    Levitsky J; Mailliard ME
    Semin Liver Dis; 2004 Aug; 24(3):233-47. PubMed ID: 15349802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
    Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
    J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for alcoholic liver disease.
    Jaurigue MM; Cappell MS
    World J Gastroenterol; 2014 Mar; 20(9):2143-58. PubMed ID: 24605013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
    Manley S; Ding W
    Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholic liver disease-from steatosis to cirrhosis - a biochemistry approach.
    Cioarca-Nedelcu R; Atanasiu V; Stoian I
    J Med Life; 2021; 14(5):594-599. PubMed ID: 35027961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and Disease Burden of Alcohol Associated Liver Disease.
    Aslam A; Kwo PY
    J Clin Exp Hepatol; 2023; 13(1):88-102. PubMed ID: 36647400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study.
    Kaushal K; Agarwal S; Sharma S; Goswami P; Singh N; Sachdev V; Poudel S; Das P; Yadav R; Kumar D; Pandey G; Gunjan D; Saraya A
    J Clin Exp Hepatol; 2022; 12(4):1102-1113. PubMed ID: 35814507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and treating patients with alcoholic cirrhosis: an update.
    Addolorato G; Russell M; Albano E; Haber PS; Wands JR; Leggio L
    Alcohol Clin Exp Res; 2009 Jul; 33(7):1136-44. PubMed ID: 19389182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
    Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
    Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
    Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.